Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators
Open Access
- 4 November 2022
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 131 (6) , 712-719
Abstract
Objectives: To address the association of perioperative surgical checklist across variable surgical expertise with transurethral resection of bladder tumour (TURBT) accuracy and oncological outcomes in non‐muscle‐invasive bladder cancer. Patients and Methods: We relied on our prospective collaborative database of patients treated with TURBT between 2012 and 2017. Surgical experience was stratified into three groups: resident vs young vs expert consultants. The association of surgical experience with detrusor muscle (DM) presence and adherence to the standardised peri‐procedural nine‐items TURBT checklist was evaluated with logistic regression models. A Cox regression model was used to investigate the association of surgical experience with recurrence‐free survival (RFS). Results: A total of 503 patients were available for analysis. TURBT was performed by expert consultants in 265 (52.7%) patients, by young consultants in 149 (29.6%) and by residents in 89 (17.7%). Residents were more likely to have DM in the TURBT specimen than expert consultants (odds ratio [OR] 1.75, 95% confidence interval [CI] 1.03–2.99, P = 0.04). Conversely, no differences in DM presence were seen between young vs expert consultants (OR 1.09, 95% CI 0.71–1.70, P = 0.69). The median checklist completion rate was higher for both residents and young consultants when compared to experts' counterparts (56% and 56% vs 44%, P = 0.009). When focusing on patients receiving a second‐look TURBT, the persistent disease was associated with resident status (OR 4.24, 95% CI 1.14–17.70, P = 0.037) at initial TURBT. Surgical experience was not associated with 5‐years RFS. Conclusion: Surgeon's experience in the case of adequate perioperative surgical checklist implementation was inversely associated with the presence of DM in the specimen but directly linked to higher probability of persistent disease at re‐TURBT, although no 5‐year RFS differences were noted.Keywords
This publication has 15 references indexed in Scilit:
- Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder TumoursEuropean Urology Oncology, 2021
- Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non–muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland’s Quality Performance Indicators ProgrammeEuropean Urology, 2020
- The Learning Curve for Transurethral Resection of Bladder Tumour: How Many is Enough to be Independent, Safe and Effective Surgeon?Journal of Surgical Education, 2020
- Association between surgical case volume and survival in T1 bladder cancer: A plea for regionalization of care?Canadian Urological Association Journal, 2020
- Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?Urologic Oncology: Seminars and Original Investigations, 2020
- Surgical checklist impact on recurrence‐free survival of patients with non‐muscle‐invasive bladder cancer undergoing transurethral resection of bladder tumourBJU International, 2018
- A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder TumorJournal of Urology, 2016
- Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomesScandinavian Journal of Urology, 2015
- Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancerScandinavian Journal of Urology, 2013
- Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator ExperienceEuropean Urology, 2010